Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound: The TOGETHAR trial

Circulation Journal

Volumn 74, Issue 9, 2010, Pages 1922-1928

  Kodama, Kazuhisa ^a,b   Komatsu, Sei ^a   Ueda, Yasunori ^d   Takayama, Tadateru ^b   Yajima, Jyunji ^c   Nanto, Shinsuke ^e   Matsuoka, Hiroshi ^f   Saito, Satoshi ^b   Hirayama, Atsushi ^b  

^a Amagasaki Central Hospital   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c THE CARDIOVASCULAR INSTITUTE   (Japan)

^d OSAKA POLICE HOSPITAL   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f Ehime Prefectural Imabari Hospital   (Japan)

Author keywords

Coronary angioscopy; Intravascular ultrasound; Pitavastatin; Plaque regression; Plaque stabilization

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PITAVASTATIN;

ACUTE HEART FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGIOSCOPY; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; ECZEMA; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE URINE LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRAVASCULAR ULTRASOUND; MALE; OPEN STUDY; PROGNOSIS; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIDE EFFECT; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOSCOPY; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; DRUG MONITORING; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; QUINOLINES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77956108426     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0038     Document Type: Article

References (31)

1. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.
2. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial. JAMA 2001; 285: 1711-1718.
3. Athyros VG, Kakafika AI, Papageorgiou AA, Araskevas KI, Tziomalos K, Anagnostis P, et al. Effects of statin treatment in men and women with stable coronary heart disease: A subgroup analysis of the GREACE Study. Curr Med Res Opin 2008; 24: 1593-1599.
4. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-1435.
5. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al; REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004; 291: 1071-1080.
6. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al; ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006; 295: 1556-1565.
7. Miyauchi K, Kimura T, Morimoto T, Nakagawa Y, Yamagishi M, Ozaki Y, et al. Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS): Rationale and design. Circ J 2006; 70: 1624-1628.
8. Toi T, Taguchi I, Yoneda S, Kageyama M, Kikuchi A, Tokura M, et al. Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque: Comparison with atorvastatin. Circ J 2009; 73: 1466-1472.
9. Kodama K, Asakura M, Ueda Y, Yamaguchi O, Hirayama A. The role of plaque rupture in the development of acute coronary syndrome evaluated by the coronary angioscope. Intern Med 2000; 39: 333-335.
10. Ueda Y, Asakura M, Hirayama A, Adachi T, Kodama K. Angioscopy of culprit lesions. Cardiologia 1997; 42: 827-832.
11. Ueda Y, Ohtani T, Shimizu M, Hirayama A, Kodama K. Assessment of plaque vulnerability by angioscopic classification of plaque color. Am Heart J 2004; 148: 333-335.
12. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: 1664-1672.
13. Hirayama A, Saito S, Ueda Y, Takayama T, Honye J, Komatsu S, et al. Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. Circ J 2009; 73: 718-725.
14. Komatsu S, Sato Y, Ueda Y, Achenbach S, Ebihara Y, Hirayama A, et al. Thrombotic occlusion proximal to plaque rupture in acute myocardial infarction; evaluation by intravascular ultrasound and coronary angioscopy. Int J Cardiol 2007; 123: e12-e14.
15. Komatsu S, Hirayama A, Ueda Y, Okuyama Y, Ogasawara N, Kashiwase K, et al. Coronary ruptured plaque mimicking spontaneous coronary dissection in a young woman. Int J Cardiol 2006; 113: 288-289.
16. Higo T, Ueda Y, Oyabu J, Okada K, Nishio M, Hirata A, et al. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: An angioscopic study. JACC Cardiovasc Imaging 2009; 2: 616-624.
17. Oyabu J, Ueda Y, Ogasawara N, Okada K, Hirayama A, Kodama K. Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent. Am Heart J 2006; 152: 1168-1174.
18. Ueda Y, Asakura M, Yamaguchi O, Hirayama A, Hori M, Kodama K. The healing process of infarct-related plaques: Insights from 18 months of serial angioscopic follow-up. J Am Coll Cardiol 2001; 38: 1916-1922.
19. Asakura M, Ueda Y, Yamaguchi O, Adachi T, Hirayama A, Hori M, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: An angioscopic study. J Am Coll Cardiol 2001; 37: 1284-1288.
20. Ohtani T, Ueda Y, Mizote I, Oyabu J, Okada K, Hirayama A, et al. Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: Detection of vulnerable patients by angioscopy. J Am Coll Cardiol 2006; 47: 2194-2200.
21. Davies MJ, Thomas AC. Plaque fissuring: The cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985; 53: 363-373.
22. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993; 87: 1781-1791.
23. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Implication of plaque color classification for assessing plaque vulnerability: A coronary angioscopy and optical coherence tomography investigation. JACC Cardiovasc Interv 2008; 1: 74-80.
24. Kawasaki M, Sano K, Okubo M, Yokoyama H, Ito Y, Murata I, et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005; 45: 1946-1953.
25. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, et al. Early statin treatment in patients with acute coronary syndrome: Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH Study. Circulation 2004; 110: 1061-1068.
26. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, et al; JAPAN-ACS Investigators. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: A multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol 2009; 54: 293-302.
27. Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, et al; for the COSMOS Investigators. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: The multicenter Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in Japanese Subjects (COSMOS). Circ J 2009; 73: 2110-2117.
28. Schartl M, Bocksch W, Koshyk DH, Voelker W, Karsch KR, Kreuzer J, et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001; 104: 387-392.
29. Ray KK, Cannon CP, Cairns R, Morrow DA, Rifai N, Kirtane AJ, et al; PROVE IT-TIMI 22 Investigators. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2005; 46: 1417-1424.
30. Yokoyama T, Miyauchi K, Kurata T, Satoh H, Daida H. Inhibitory efficacy of pitavastatin on the early inflammatory response and neointimal thickening in a porcine coronary after stenting. Atherosclerosis 2004; 174: 253-259.
31. Takarada S, Imanishi T, Kubo T, Tanimoto T, Kitabata H, Nakamura N, et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: Assessment by optical coherence tomography study. Atherosclerosis 2009; 202: 491-497.